SCHEMBL8429005

SCHEMBL8429005

Cc1c(SCCCCl)ccnc1CSc1nc2cc(F)c(F)cc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.43
CYP3A4 P08684 4/20 0.43
CYP2D6 P10635 4/20 0.43
CYP2C9 P11712 4/20 0.43
CYP2C19 P33261 4/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
BRS3 P32247 1/20 0.40
OPRL1 P41146 10/20 0.39
CYP2E1 P05181 3/20 0.38
CYP2C8 P10632 3/20 0.38
CYP2B6 P20813 3/20 0.38
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
EPHX2 P34913 1/20 0.35
HRH4 Q9H3N8 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
NFKB1 P19838 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8428878 0.99 CYP1A2 (0.43) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL8427172 0.91 CYP1A2 (0.44) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL8426932 0.90 CYP1A2 (0.43) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL8426996 0.89 RAB9A (0.45) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL7807341 0.84 NPC1 (0.58) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL8412597 0.81 NPC1 (0.57) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
Benzenethiol SCHEMBL8685398 0.79 NPC1 (0.52) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL8805150 0.79 RAB9A (0.54) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL10336030 0.79 CYP2D6 (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL7812133 0.79 NPC1 (0.59) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5922720-A PHARMACEUTICAL FOR USE IN TREATMENT OF DISEASES BASED ON HELICOBACTER BACTERIA BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1999-07-13 US disclosed